Drug Profile
Research programme: anti-LRG1 antibody therapeutics - Antitope/University College London
Latest Information Update: 28 Sep 2018
Price :
$50
*
At a glance
- Originator Antitope; University College London
- Class Antibodies
- Mechanism of Action Angiogenesis inhibitors; LRG1 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Age-related macular degeneration
Most Recent Events
- 28 Sep 2018 No recent reports of development identified for research development in Age-related-macular-degeneration in United Kingdom (Ophthalmic)
- 27 Aug 2014 Early research in Age-related macular degeneration in United Kingdom (Ophthalmic)